Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2022 07:00 ET | Source: Allergy Therapeutics

Interim Results for the six months ended 31 December 2021

Allergy Therapeutics plc(“Allergy Therapeutics” or the “Company” or the “Group”) Interim Results for the six months ended 31 December 2021 ~ US readiness plan underway including two...
June 27, 2019 10:47 ET | Source: Allergy Therapeutics

Allergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II Trial

Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Successful litigation settlement relating to PQ Grass Phase II Trial 27 June 2019 Allergy Therapeutics plc (AIM: AGY), the...
June 27, 2019 10:26 ET | Source: Allergy Therapeutics

Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement

Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June...
July 12, 2018 07:00 ET | Source: Allergy Therapeutics

Allergy Therapeutics PLC: Trading Update

Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated...
May 29, 2018 07:00 ET | Source: Allergy Therapeutics

Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapy

Allergy Therapeutics plc("Allergy Therapeutics", the “Group” or “Company") Positive new clinical data with house-dust mite immunotherapy ~ House-dust mite immunotherapy shown to be well-tolerated...